135 related articles for article (PubMed ID: 1663053)
1. Calcemic response to magnesium or 1-alpha-hydroxycholecalciferol treatment in intestinal hypomagnesemia.
Ducreux M; Messing B; De Vernejoul MC; Bouhnik Y; Miravet L; Rambaud JC
Gastroenterol Clin Biol; 1991; 15(11):805-11. PubMed ID: 1663053
[TBL] [Abstract][Full Text] [Related]
2. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function.
Suh SM; Tashjian AH; Matsuo N; Parkinson DK; Fraser D
J Clin Invest; 1973 Jan; 52(1):153-60. PubMed ID: 4345201
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone secretion and responsiveness to parathyroid hormone in primary hypomagnesemia.
Garty R; Alkalay A; Bernheim JL
Isr J Med Sci; 1983 Apr; 19(4):345-8. PubMed ID: 6853131
[TBL] [Abstract][Full Text] [Related]
6. Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency.
Rude RK; Adams JS; Ryzen E; Endres DB; Niimi H; Horst RL; Haddad JG; Singer FR
J Clin Endocrinol Metab; 1985 Nov; 61(5):933-40. PubMed ID: 3840173
[TBL] [Abstract][Full Text] [Related]
7. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
[TBL] [Abstract][Full Text] [Related]
8. [Response of vitamin D metabolites to calcium restriction in hypercalciuric renal lithiasis].
Saro Gutiérrez G; Riancho Moral JA; Amado Señaris JA; Pracht Ferrer C; González Macías J
Med Clin (Barc); 1990 Mar; 94(10):361-3. PubMed ID: 2159577
[TBL] [Abstract][Full Text] [Related]
9. Hypomagnesemia masking the appearance of elevated parathyroid hormone concentrations in familial pseudohypoparathyroidism.
Allen DB; Friedman AL; Greer FR; Chesney RW
Am J Med Genet; 1988 Sep; 31(1):153-8. PubMed ID: 3223496
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent.
Hirschel-Scholz S; Caverzasio J; Bonjour JP
J Clin Invest; 1985 Nov; 76(5):1851-6. PubMed ID: 2997292
[TBL] [Abstract][Full Text] [Related]
11. Bone demineralization and impaired mineral metabolism in insulin-dependent diabetes mellitus. A possible role of magnesium deficiency.
Saggese G; Bertelloni S; Baroncelli GI; Federico G; Calisti L; Fusaro C
Helv Paediatr Acta; 1989 Jun; 43(5-6):405-14. PubMed ID: 2787312
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis.
Chesney RW; Hamstra A; Rose P; DeLuca HF
Int J Pediatr Nephrol; 1984 Mar; 5(1):1-4. PubMed ID: 6715110
[TBL] [Abstract][Full Text] [Related]
13. Aminoaciduria of vitamin D deficiency is independent of PTH levels and urinary cyclic AMP.
Dabbagh S; Chesney R; Gusowski N; Mathews MC; Padilla M; Theissen M; Slatopolsky E
Miner Electrolyte Metab; 1989; 15(4):221-32. PubMed ID: 2548072
[TBL] [Abstract][Full Text] [Related]
14. Calcium metabolism and calciotropic hormone levels in Gitelman's syndrome.
Colussi G; Macaluso M; Brunati C; Minetti L
Miner Electrolyte Metab; 1994; 20(5):294-301. PubMed ID: 7700218
[TBL] [Abstract][Full Text] [Related]
15. Renal magnesium wasting in a patient with short bowel syndrome with magnesium deficiency: effect of 1 alpha-hydroxyvitamin D3 treatment.
Fukumoto S; Matsumoto T; Tanaka Y; Harada S; Ogata E
J Clin Endocrinol Metab; 1987 Dec; 65(6):1301-4. PubMed ID: 3680484
[TBL] [Abstract][Full Text] [Related]
16. [Hyperparathyroidism secondary to cirrhosis. Arguments supplied by ionized calcium, urinary cyclic AMP and blood N-terminal parathyroid hormone].
Louboutin JY; Feuillu A; Allain H; Bernat M; Meadeb J; Pawlotsky Y
Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):707-13. PubMed ID: 6256846
[TBL] [Abstract][Full Text] [Related]
17. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.
Rude RK; Oldham SB; Singer FR
Clin Endocrinol (Oxf); 1976 May; 5(3):209-24. PubMed ID: 182417
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D physiology.
Lips P
Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
[TBL] [Abstract][Full Text] [Related]
19. Effect of magnesium on phosphorus and calcium metabolism.
Paunier L
Monatsschr Kinderheilkd; 1992 Sep; 140(9 Suppl 1):S17-20. PubMed ID: 1331782
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. Interactions of parathyroid hormone, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol.
Llach F; Felsenfeld AJ; Haussler MR
N Engl J Med; 1981 Jul; 305(3):117-23. PubMed ID: 6894630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
